Literature DB >> 19178896

Risk factors and outcome of early recurrence after resection of small hepatocellular carcinomas.

Masaki Kaibori1, Morihiko Ishizaki, Takamichi Saito, Kosuke Matsui, A-Hon Kwon, Yasuo Kamiyama.   

Abstract

BACKGROUND: This study aimed to clarify risk factors for early recurrence and examine the subsequent outcome in patients undergoing potentially R0 resection of small hepatocellular carcinomas (HCCs) (<or=2 cm in greatest dimension).
METHODS: Eighty-nine patients were divided into 2 groups as follows: 26 patients suffering from recurrence within 2 years of surgery (early recurrence group) and 63 patients who were disease-free for at least 2 years (disease-free 2Y group).
RESULTS: Only 7 of 63 patients (11%) from the group that was disease-free for at least 2 years died during the 5-year period after surgery, whereas 13 of 26 patients (50%) from the early recurrence group died. Multivariate analysis showed that the preoperative maximum removal rate of technetium-99m-diethylenetriamine pentaacetic acid-galactosyl human serum albumin and microscopic vascular invasion were independent predictors of the early recurrence of small HCC.
CONCLUSIONS: Early recurrence of small HCC is the leading cause of death within 5 years after R0 resection. The preoperative hepatic functional reserve influences early recurrence, even in patients with small tumors.

Entities:  

Mesh:

Year:  2009        PMID: 19178896     DOI: 10.1016/j.amjsurg.2008.07.051

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  17 in total

1.  Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma.

Authors:  Kazumasa Hiroishi; Junichi Eguchi; Toshiyuki Baba; Tomoe Shimazaki; Shigeaki Ishii; Ayako Hiraide; Masashi Sakaki; Hiroyoshi Doi; Shojiro Uozumi; Risa Omori; Takuya Matsumura; Tatsuro Yanagawa; Takayoshi Ito; Michio Imawari
Journal:  J Gastroenterol       Date:  2009-11-20       Impact factor: 7.527

2.  Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system.

Authors:  Albert C Y Chan; Sheung Tat Fan; Ronnie T P Poon; Tan To Cheung; Kenneth S H Chok; See Ching Chan; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2012-12-02       Impact factor: 3.647

3.  Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.

Authors:  Tomoki Kobayashi; Hiroshi Aikata; Masahiro Hatooka; Kei Morio; Reona Morio; Hiromi Kan; Hatsue Fujino; Takayuki Fukuhara; Keiichi Masaki; Atsushi Ohno; Noriaki Naeshiro; Takashi Nakahara; Yohji Honda; Eisuke Murakami; Tomokazu Kawaoka; Masataka Tsuge; Akira Hiramatsu; Michio Imamura; Yoshiiku Kawakami; Hideyuki Hyogo; Shoichi Takahashi; Kazuaki Chayama
Journal:  Eur Radiol       Date:  2015-06-03       Impact factor: 5.315

4.  Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.

Authors:  Jean-Nicolas Vauthey; Elijah Dixon; Eddie K Abdalla; W Scott Helton; Timothy M Pawlik; Bachir Taouli; Antoine Brouquet; Reid B Adams
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

5.  Correlation of LAPTM4B polymorphisms with hepatocellular carcinoma in Chinese patients.

Authors:  Guojun Zhai; Hua Yang; Xiaoxu Ji; Fuxia Xiong; Jing Su; Michael A McNutt; Xuan Li
Journal:  Med Oncol       Date:  2011-12-30       Impact factor: 3.064

6.  Prognostic impact of preoperative the branched-chain amino acid to the tyrosine ratio in hepatocellular carcinoma patients after initial hepatectomy.

Authors:  Toru Mizuguchi; Masaki Kawamoto; Makoto Meguro; Yukio Nakamura; Kohei Harada; Kazuharu Kukita; Koichi Hirata
Journal:  J Gastrointest Surg       Date:  2011-05-24       Impact factor: 3.452

7.  Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.

Authors:  T T Zhang; X Q Zhao; Z Liu; Z Y Mao; L Bai
Journal:  Clin Transl Oncol       Date:  2015-11-17       Impact factor: 3.405

8.  LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.

Authors:  Hua Yang; Fu Xia Xiong; Ming Lin; Yu Yang; Xiu Nie; Rou Li Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-19       Impact factor: 4.553

9.  Reduced expression of ASS is closely related to clinicopathological features and post-resectional survival of hepatocellular carcinoma.

Authors:  Hua Yang; Ming Lin; Fu Xia Xiong; Yu Yang; Xiu Nie; Rou Li Zhou
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

10.  GAB2 promotes cell proliferation by activating the ERK signaling pathway in hepatocellular carcinoma.

Authors:  Yuyan Chen; Qingqing Liu; Miaomiao Wu; Manhua Li; Haifang Ding; Xiaohang Shan; Jinxia Liu; Tao Tao; Runzhou Ni; Xudong Chen
Journal:  Tumour Biol       Date:  2016-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.